In conclusion, we found that remdesivir-treated and non-treated patients exhibited distinct sociodemographic and physiological characteristics. Also, the use of other COVID-19 treatments evolved differently between remdesivir-treated and not treated over time.
Hoe et al. (2026) studied this question.